Page last updated: 2024-11-06

2,2-bis(3-chloro-4-hydroxyphenyl)propane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,2-bis(3-chloro-4-hydroxyphenyl)propane: has estrogenic activity; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID66238
SCHEMBL ID37041
MeSH IDM0482150

Synonyms (40)

Synonym
ENAMINE_005935
3,3'-dichlorodian
nsc18247
4,4'-isopropylidenebis[2-chlorophenol]
2,2-bis(4-hydroxy-3-chlorophenyl)propane
79-98-1
phenol,4'-isopropylidenebis[2-chloro-
nsc-18247
3,3'-dichlorobisphenol a
phenol,4'-(1-methylethylidene)bis[2-chloro-
2,2-bis(3-chloro-4-hydroxyphenyl)propane
OPREA1_815250
nsc 18247
einecs 201-241-6
4,4'-isopropylidenebis(2-chlorophenol)
4,4'-isopropylidenebis(o-chlorophenol)
phenol, 4,4'-(1-methylethylidene)bis(2-chloro-
phenol, 4,4'-isopropylidenebis(2-chloro-
IDI1_008170
HMS1410N17
2-chloro-4-[2-(3-chloro-4-hydroxyphenyl)propan-2-yl]phenol
FT-0666557
unii-ws963ra8kz
ws963ra8kz ,
4,4'-(1-methylethylidene)bis[2-chlorophenol]
2,2-di(4-hydroxy-3-chlorophenyl)propane
phenol, 4,4'-(1-methylethylidene)bis[2-chloro-
SCHEMBL37041
2,2-bis(3-chloro,-4-hydroxyphenyl)propane
2,2-bis-(4-hydroxy-3-chlorphenyl)-propane
DTXSID3058826
4,4'-isopropylidenebis[o-chlorophenol]
4,4'-isopropylidene-bis(2-chlorophenol)
sr-01000596913
SR-01000596913-1
2,2'-dichloro bisphenol a
AS-6196
4,4'-(propane-2,2-diyl)bis(2-chlorophenol)
2,2-bis(3-chloro-4-hydroxyphenyl) propane
AKOS037645642
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.91 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]